Advanced search
Publication Cover
OncoImmunology Volume 7, 2018 - Issue 2
Submit an article Journal homepage
2,374
Views
29
CrossRef citations to date
0
Altmetric
Original Research

Antigenic expression and spontaneous immune responses support the use of a selected peptide set from the IMA950 glioblastoma vaccine for immunotherapy of grade II and III glioma

Valérie DutoitDepartment of Oncology, Geneva University Hospital, Rue Gabrielle-Perret-Gentil 4, 1204 Geneva 11, Switzerland and Department of Internal Medicine Specialties, Faculty of Medicine, University of Geneva, Rue Michel-Servet 1, 1205GenevaSwitzerland
,
Denis MiglioriniDepartment of Oncology, Geneva University Hospital, Rue Gabrielle-Perret-Gentil 4, 1204 Geneva 11, Switzerland and Department of Internal Medicine Specialties, Faculty of Medicine, University of Geneva, Rue Michel-Servet 1, 1205GenevaSwitzerland
,
Giulia RanzaniciDepartment of Oncology, Geneva University Hospital, Rue Gabrielle-Perret-Gentil 4, 1204 Geneva 11, Switzerland and Department of Internal Medicine Specialties, Faculty of Medicine, University of Geneva, Rue Michel-Servet 1, 1205GenevaSwitzerland
,
Eliana MarinariDepartment of Oncology, Geneva University Hospital, Rue Gabrielle-Perret-Gentil 4, 1204 Geneva 11, Switzerland and Department of Internal Medicine Specialties, Faculty of Medicine, University of Geneva, Rue Michel-Servet 1, 1205GenevaSwitzerland
,
Valérie WidmerDepartment of Oncology, Geneva University Hospital, Rue Gabrielle-Perret-Gentil 4, 1204 Geneva 11, Switzerland and Department of Internal Medicine Specialties, Faculty of Medicine, University of Geneva, Rue Michel-Servet 1, 1205GenevaSwitzerland
,
Johannes Alexander LobrinusDivision of Clinical Pathology, Geneva University Hospitals and University of Geneva, Rue Gabrielle-Perret-Gentil 4, 1204 Geneva 11, Switzerland
,
Shahan MomjianNeurosurgery Service, Geneva University Hospitals and University of Geneva, Rue Gabrielle-Perret-Gentil 4, 1204 Geneva 11, Switzerland
,
Joseph CostelloBrain Tumor Research Centre, Department of Neurosurgery, University of California San Francisco, 505 Parnassus Ave, Room 779 M, San Francisco, CA, USA
,
Paul R. WalkerDepartment of Oncology, Geneva University Hospital, Rue Gabrielle-Perret-Gentil 4, 1204 Geneva 11, Switzerland and Department of Internal Medicine Specialties, Faculty of Medicine, University of Geneva, Rue Michel-Servet 1, 1205GenevaSwitzerland
,
Hideho OkadaBrain Tumor Research Centre, Department of Neurosurgery, University of California San Francisco, 505 Parnassus Ave, Room 779 M, San Francisco, CA, USA;Cancer Immunotherapy Program, University of California San Francisco and The Parker Institute for Cancer Immunotherapy, 1 Letterman Drive, Suite D3500, San Francisco, CA, USA
,
Toni WeinschenkImmatics Biotechnologies GmbH, Paul-Ehrlich-Strasse 15, Tübingen, Germany
,
Christel Herold-MendeDivision of Experimental Neurosurgery, Department of Neurosurgery, University of Heidelberg, Im Neuenheimer Feld 400, Heidelberg, Germany
&
Pierre-Yves DietrichDepartment of Oncology, Geneva University Hospital, Rue Gabrielle-Perret-Gentil 4, 1204 Geneva 11, Switzerland and Department of Internal Medicine Specialties, Faculty of Medicine, University of Geneva, Rue Michel-Servet 1, 1205GenevaSwitzerlandCorrespondence[email protected]
 show all
Article: e1391972 | Received 07 Jul 2017, Accepted 09 Oct 2017, Published online: 07 Nov 2017

Citations (29)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Amit Lath, Anita Rani Santal, Nameet Kaur, Poonam Kumari & Nater Pal Singh. (2023) Anti-cancer peptides: their current trends in the development of peptide-based therapy and anti-tumor drugs. Biotechnology and Genetic Engineering Reviews 39:1, pages 45-84.
Read now
Isaure Vanmeerbeek, Jenny Sprooten, Dirk De Ruysscher, Sabine Tejpar, Peter Vandenberghe, Jitka Fucikova, Radek Spisek, Laurence Zitvogel, Guido Kroemer, Lorenzo Galluzzi & Abhishek D. Garg. (2020) Trial watch: chemotherapy-induced immunogenic cell death in immuno-oncology. OncoImmunology 9:1.
Read now
Melody Smith, Elena García-Martínez, Michael R. Pitter, Jitka Fucikova, Radek Spisek, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2018) Trial Watch: Toll-like receptor agonists in cancer immunotherapy. OncoImmunology 7:12.
Read now
Elena García-Martínez, Melody Smith, Aitziber Buqué, Fernando Aranda, Francisco Ayala de la Peña, Alejandra Ivars, Manuel Sanchez Cánovas, Ma Angeles Vicente Conesa, Jitka Fucikova, Radek Spisek, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2018) Trial Watch: Immunostimulation with recombinant cytokines for cancer therapy. OncoImmunology 7:6.
Read now

Articles from other publishers (25)

Qingqing Zhou, Yamei Wang, Chenqi Xin, XiaoMing Wei, Yuan Yao & Liang Xia. (2024) Identification of telomere-associated gene signatures to predict prognosis and drug sensitivity in glioma. Computers in Biology and Medicine 168, pages 107750.
Crossref
Vahab Alamdari-palangi, Khojaste Rahimi Jaberi, Mahshid Shahverdi, Yasaman Naeimzadeh, Amir Tajbakhsh, Sahar Khajeh, Vahid Razban & Jafar Fallahi. (2023) Recent advances and applications of peptide–agent conjugates for targeting tumor cells. Journal of Cancer Research and Clinical Oncology 149:16, pages 15249-15273.
Crossref
Atsuro Saijo, Hirokazu Ogino, Nicholas A Butowski, Meghan R Tedesco, David Gibson, Payal B Watchmaker, Kaori Okada, Albert S Wang, Anny Shai, Andres M Salazar, Annette M Molinaro, Jane E Rabbitt, Maryam Shahin, Arie Perry, Jennifer L Clarke, Jennie W Taylor, Mariza Daras, Nancy Ann Oberheim Bush, Shawn L Hervey-Jumper, Joanna J Phillips, Susan M Chang, Norbert Hilf, Andrea Mayer-Mokler, Tibor Keler, Mitchel S Berger & Hideho Okada. (2023) A combinatory vaccine with IMA950 plus varlilumab promotes effector memory T-cell differentiation in the peripheral blood of patients with low-grade gliomas. Neuro-Oncology.
Crossref
Jin Nan, Wei Yang, Yujie Xie, Meihua Yu, Yu Chen & Jun Zhang. (2023) Emerging Nano‐Immunotherapeutic Approaches to Glioma. Small Structures 4:8.
Crossref
Evangelia Papadimitriou & Vasiliki K. Kanellopoulou. (2023) Protein Tyrosine Phosphatase Receptor Zeta 1 as a Potential Target in Cancer Therapy and Diagnosis. International Journal of Molecular Sciences 24:9, pages 8093.
Crossref
Stefaan W. Van Gool, Peter Van de Vliet, Linde F.C. Kampers, Jennifer Kosmal, Tobias Sprenger, Ella Reich, Volker Schirrmacher & Wilfried Stuecker. 2023.
Jian Wang, Tobias Weiss, Marian C. Neidert, Nora C. Toussaint, Reza Naghavian, Carla Sellés Moreno, Magdalena Foege, Paula Tomas Ojer, Gioele Medici, Ivan Jelcic, Daniel Schulz, Elisabeth Rushing, Susanne Dettwiler, Barbara Schrörs, Joo Heon Shin, Ron McKay, Catherine J. Wu, Andreas Lutterotti, Mireia Sospedra, Holger Moch, Erich F. Greiner, Bernd Bodenmiller, Luca Regli, Michael Weller, Patrick Roth & Roland Martin. (2022) Vaccination with Designed Neopeptides Induces Intratumoral, Cross-reactive CD4+ T-cell Responses in Glioblastoma. Clinical Cancer Research 28:24, pages 5368-5382.
Crossref
Xuehua Zhang, Leilei Zhao, He Zhang, Yurui Zhang, Huanyu Ju, Xiaoyu Wang, Huan Ren, Xiao Zhu & Yucui Dong. (2022) The immunosuppressive microenvironment and immunotherapy in human glioblastoma. Frontiers in Immunology 13.
Crossref
Guichuan Lai, Xiaoni Zhong, Hui Liu, Jielian Deng, Kangjie Li & Biao Xie. (2022) Development of a Hallmark Pathway-Related Gene Signature Associated with Immune Response for Lower Grade Gliomas. International Journal of Molecular Sciences 23:19, pages 11971.
Crossref
Phasit Charoenkwan, Nalini Schaduangrat, Pietro Lio', Mohammad Ali Moni, Balachandran Manavalan & Watshara Shoombuatong. (2022) NEPTUNE: A novel computational approach for accurate and large-scale identification of tumor homing peptides. Computers in Biology and Medicine 148, pages 105700.
Crossref
Ji Su Hwang, Seok Gi Kim, Tae Hwan Shin, Yong Eun Jang, Do Hyeon Kwon & Gwang Lee. (2022) Development of Anticancer Peptides Using Artificial Intelligence and Combinational Therapy for Cancer Therapeutics. Pharmaceutics 14:5, pages 997.
Crossref
Eugene I. Hwang, Elias J. Sayour, Catherine T. Flores, Gerald Grant, Robert Wechsler-Reya, Lan B. Hoang-Minh, Mark W. Kieran, Joanne Salcido, Robert M. Prins, John W. Figg, Michael Platten, Kate M. Candelario, Paul G. Hale, Jason E. Blatt, Lance S. Governale, Hideho Okada, Duane A. Mitchell & Ian F. Pollack. (2022) The current landscape of immunotherapy for pediatric brain tumors. Nature Cancer 3:1, pages 11-24.
Crossref
Phasit Charoenkwan, Wararat Chiangjong, Chanin Nantasenamat, Mohammad Ali Moni, Pietro Lio’, Balachandran Manavalan & Watshara Shoombuatong. (2022) SCMTHP: A New Approach for Identifying and Characterizing of Tumor-Homing Peptides Using Estimated Propensity Scores of Amino Acids. Pharmaceutics 14:1, pages 122.
Crossref
Orsolya Lőrincz, József Tóth, Levente Molnár, István Miklós, Kata Pántya, Mónika Megyesi, Eszter Somogyi, Zsolt Csiszovszki & Enikő R. Tőke. (2021) In Silico Model Estimates the Clinical Trial Outcome of Cancer Vaccines. Cells 10:11, pages 3048.
Crossref
Pavlina Chuntova, Frances Chow, Payal B Watchmaker, Mildred Galvez, Amy B Heimberger, Evan W Newell, Aaron Diaz, Ronald A DePinho, Ming O Li, E John Wherry, Duane Mitchell, Masaki Terabe, Derek A Wainwright, Jay A Berzofsky, Christel Herold-Mende, James R Heath, Michael Lim, Kim A Margolin, E Antonio Chiocca, Noriyuki Kasahara, Benjamin M Ellingson, Christine E Brown, Yvonne Chen, Peter E Fecci, David A Reardon, Gavin P Dunn, Linda M Liau, Joseph F Costello, Wolfgang Wick, Timothy Cloughesy, William C Timmer, Patrick Y Wen, Robert M Prins, Michael Platten & Hideho Okada. (2021) Unique challenges for glioblastoma immunotherapy—discussions across neuro-oncology and non-neuro-oncology experts in cancer immunology. Meeting Report from the 2019 SNO Immuno-Oncology Think Tank. Neuro-Oncology 23:3, pages 356-375.
Crossref
Greta Forlani, Justine Michaux, HuiSong Pak, Florian Huber, Elodie Lauret Marie Joseph, Elise Ramia, Brian J. Stevenson, Michael Linnebacher, Roberto S. Accolla & Michal Bassani-Sternberg. (2021) CIITA-Transduced Glioblastoma Cells Uncover a Rich Repertoire of Clinically Relevant Tumor-Associated HLA-II Antigens. Molecular & Cellular Proteomics 20, pages 100032.
Crossref
Sjoerd T.T. Schetters, R.J. Eveline Li, Laura J.W. Kruijssen, Steef Engels, Martino Ambrosini, Juan J. Garcia-Vallejo, Hakan Kalay, Wendy W.J. Unger & Yvette van Kooyk. (2020) Adaptable antigen matrix platforms for peptide vaccination strategies and T cell-mediated anti-tumor immunity. Biomaterials 262, pages 120342.
Crossref
Takahide Nejo, Abigail Mende & Hideho Okada. (2020) The current state of immunotherapy for primary and secondary brain tumors: similarities and differences. Japanese Journal of Clinical Oncology 50:11, pages 1231-1245.
Crossref
Huang Xueqing, Zhang Jun, Jiang Yueqiang, Liao Xin, Hu Liya, Fang Yuanyuan, Zhang Yuting, Zeng Hao, Wu Hua, Liu Jian & Yin Tiejun. (2020) IGF2BP3 May Contributes to Lung Tumorigenesis by Regulating the Alternative Splicing of PKM. Frontiers in Bioengineering and Biotechnology 8.
Crossref
Jacob S. Young, Andrew J. Gogos, Ramin A. Morshed, Shawn L. Hervey-Jumper & Mitchel S. Berger. (2020) Molecular characteristics of diffuse lower grade gliomas: what neurosurgeons need to know. Acta Neurochirurgica 162:8, pages 1929-1939.
Crossref
Boris I. Chobrutskiy, Michelle Yeagley, Price Tipping, Saif Zaman, Andrea Diviney, Dhruv N. Patel, Shayan Falasiri, Vladimir N. Uversky & George Blanck. (2019) Chemical complementarity between immune receptor CDR3s and IDH1 mutants correlates with increased survival for lower grade glioma. Oncogene 39:8, pages 1773-1783.
Crossref
Hongxiang Wang, Tao Xu, Qilin Huang, Weilin Jin & Juxiang Chen. (2020) Immunotherapy for Malignant Glioma: Current Status and Future Directions. Trends in Pharmacological Sciences 41:2, pages 123-138.
Crossref
Takahide Nejo, Akane Yamamichi, Neil D. Almeida, Yitzhar E. Goretsky & Hideho Okada. (2020) Tumor antigens in glioma. Seminars in Immunology 47, pages 101385.
Crossref
J. Qi, D. R. Esfahani, T. Huang, P. Ozark, E. Bartom, R. Hashizume, E. R. Bonner, S. An, C. M. Horbinski, C. D. James & A. M. Saratsis. (2019) Tenascin-C expression contributes to pediatric brainstem glioma tumor phenotype and represents a novel biomarker of disease. Acta Neuropathologica Communications 7:1.
Crossref
Masashi Nomura, Kuniaki Saito, Koki Aihara, Genta Nagae, Shogo Yamamoto, Kenji Tatsuno, Hiroki Ueda, Shiro Fukuda, Takayoshi Umeda, Shota Tanaka, Shunsaku Takayanagi, Ryohei Otani, Takahide Nejo, Taijun Hana, Satoshi Takahashi, Yosuke Kitagawa, Mayu Omata, Fumi Higuchi, Taishi Nakamura, Yoshihiro Muragaki, Yoshitaka Narita, Motoo Nagane, Ryo Nishikawa, Keisuke Ueki, Nobuhito Saito, Hiroyuki Aburatani & Akitake Mukasa. (2019) DNA demethylation is associated with malignant progression of lower-grade gliomas. Scientific Reports 9:1.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.